FIELD: medicine.
SUBSTANCE: in order to predict duration of tick-borne encephalitis virus antigenemia till introduction of anti-tick immunoglobulin in infected people level of spontaneous and induced production of cytokins IFN-γ and IL-4 is determined. If level of spontaneous production of IFN-γ is higher than 59.7 pg/ml, and level of induced production is higher than 122.2 pg/ml, level of spontaneous production of IL-4 being lower than 23.5 pg/ml, level of induced production being lower than 25.3 pg/ml, quick elimination of antigen is predicted.
EFFECT: method makes it possible to determine duration of antigenemia period in initial period if viral infection, which contributes to selection of correct tactics of treating patient.
3 tbl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ASSESSMENT OF DISORDER OF CELLULAR IMMUNITY IN EXPOSED TO PHENOL | 2013 |
|
RU2523418C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF TICK-BORNE ENCEPHALITIS, IXODID TICK-BORNE BORRELIOSIS AND THEIR MIXED INFECTIONS OF CHILDREN | 2010 |
|
RU2433404C1 |
| METHOD FOR EXPRESS-DIAGNOSTICS OF TICK- BORNE ENCEPHALITIS | 2001 |
|
RU2217758C2 |
| METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA AND/OR CYSTIC FIBROSIS ACCOMPANYING INFLUENZA IN CHILDREN | 2013 |
|
RU2522276C1 |
| METHOD FOR DETERMINING SPECIFIC SENSITIZATION OF LYMPHOCYTES TO TOXOPLASM | 2022 |
|
RU2797361C1 |
| METHOD OF PREPARING IMMUNOGENIC COMPOSITION BASED ON THREE FUSION PROTEINS OF SHELL OF TICK-BORNE ENCEPHALITIS VIRUS DEFINING BELONGING TO SIBERIAN (DBD2-D3S), EUROPEAN (DBD2-D3E) AND FAR EAST (DBD2-D3D) VIRUS SUBTYPES; RECOMBINANT PLASMIDS pDBD2-D3S, pDBD2-D3E AND pDBD2-D3D; PRODUCER STRAINS Escherichia coli M15 [pREP4]; CHIMERIC PROTEINS AND THEIR APPLICATION | 2014 |
|
RU2560588C1 |
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
| METHOD OF EMERGENCY PREVENTION OF TICK - BORNE ENCEPHALITIS | 2018 |
|
RU2681546C1 |
| RECOMBINANT PLASMID pHis6-flagG-protE, WHICH PROVIDES SYNTHESIS OF A RECOMBINANT CHIMERIC PROTEIN, INCLUDING EPITOPES OF GLYCOPROTEIN E OF TICK-BORNE ENCEPHALITIS VIRUS AND FLAGELLIN G SALMONELLA TYPHII AND USED AS A BASE FOR VACCINE AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2018 |
|
RU2702716C2 |
| PREVENTIVE DRUG FOR INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTION | 2009 |
|
RU2401117C1 |
